Vanguard Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Vanguard Capital Management's RMD Position: Q3 2026 in Review
Vanguard Capital Management reduced its ResMed (RMD) stake by 0.3% in Q3 2026, selling an estimated $6.13M and leaving 9,446,041 shares worth $2.09B. The position accounts for 0.04% of the portfolio, ranked #314.
Vanguard Capital Management first reported a position in RMD in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.13B in Q1 2026. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Vanguard Capital Management held 9,446,041 shares of ResMed worth $2.09B as of Q3 2026.
- Vanguard Capital Management sold 28,088 ResMed shares in Q3 2026, an estimated $6.13M.
- ResMed made up 0.04% of Vanguard Capital Management's portfolio in Q3 2026, its #314 holding.
- Vanguard Capital Management first reported a position in ResMed in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's ResMed position peaked at $2.13B in Q1 2026.
- 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.